EuroPCR 2013: The Calm After The Technology Storm
This article was originally published in The Gray Sheet
Executive Summary
For the past several years, TAVI and renal denervation have dominated EuroPCR, the largest interventional cardiology conference in Europe. This year’s conference in Paris in May was more balanced, leaving room for interest in bioresorbable stents and mitral valves.
You may also be interested in...
At PCR, Drug-Eluting Stents From Asia, But At What Cost?
No one would place drug-eluting stents among the hot technologies showcased at this year’s EuroPCR, not with all of the buzz around renal denervation, percutaneous valves, and bioabsorbable stents and scaffolds. But an early morning session on DES from India and China underscored how the technology debate is changing in a world of cost constraints and emerging markets, particularly for mature categories.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.